PCVX
Price
$78.14
Change
-$3.03 (-3.73%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
9.74B
48 days until earnings call
XNCR
Price
$19.10
Change
-$1.16 (-5.73%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
1.34B
48 days until earnings call
Ad is loading...

PCVX vs XNCR

Header iconPCVX vs XNCR Comparison
Open Charts PCVX vs XNCRBanner chart's image
Vaxcyte
Price$78.14
Change-$3.03 (-3.73%)
Volume$37.4K
Capitalization9.74B
Xencor
Price$19.10
Change-$1.16 (-5.73%)
Volume$6.55K
Capitalization1.34B
PCVX vs XNCR Comparison Chart
Loading...
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PCVX vs. XNCR commentary
Jan 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PCVX is a Hold and XNCR is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 15, 2025
Stock price -- (PCVX: $81.17 vs. XNCR: $20.26)
Brand notoriety: PCVX and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PCVX: 67% vs. XNCR: 79%
Market capitalization -- PCVX: $10.12B vs. XNCR: $1.42B
PCVX [@Biotechnology] is valued at $10.12B. XNCR’s [@Biotechnology] market capitalization is $1.42B. The market cap for tickers in the [@Biotechnology] industry ranges from $385.53B to $0. The average market capitalization across the [@Biotechnology] industry is $2.41B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PCVX’s FA Score shows that 0 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • PCVX’s FA Score: 0 green, 5 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, XNCR is a better buy in the long-term than PCVX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PCVX’s TA Score shows that 5 TA indicator(s) are bullish while XNCR’s TA Score has 3 bullish TA indicator(s).

  • PCVX’s TA Score: 5 bullish, 3 bearish.
  • XNCR’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, PCVX is a better buy in the short-term than XNCR.

Price Growth

PCVX (@Biotechnology) experienced а -5.61% price change this week, while XNCR (@Biotechnology) price change was -14.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.05%. For the same industry, the average monthly price growth was -1.49%, and the average quarterly price growth was -2.91%.

Reported Earning Dates

PCVX is expected to report earnings on May 12, 2025.

XNCR is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-7.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PCVX($9.74B) has a higher market cap than XNCR($1.34B). PCVX YTD gains are higher at: -0.843 vs. XNCR (-11.836). XNCR has higher annual earnings (EBITDA): -198.91M vs. PCVX (-528.22M). PCVX has more cash in the bank: 2.18B vs. XNCR (543M). PCVX has less debt than XNCR: PCVX (28M) vs XNCR (86.6M). XNCR has higher revenues than PCVX: XNCR (85.2M) vs PCVX (0).
PCVXXNCRPCVX / XNCR
Capitalization9.74B1.34B728%
EBITDA-528.22M-198.91M266%
Gain YTD-0.843-11.8367%
P/E RatioN/AN/A-
Revenue085.2M-
Total Cash2.18B543M401%
Total Debt28M86.6M32%
FUNDAMENTALS RATINGS
XNCR: Fundamental Ratings
XNCR
OUTLOOK RATING
1..100
75
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
5
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PCVXXNCR
RSI
ODDS (%)
Bullish Trend 7 days ago
86%
N/A
Stochastic
ODDS (%)
Bullish Trend 7 days ago
82%
Bullish Trend 7 days ago
78%
Momentum
ODDS (%)
Bearish Trend 7 days ago
82%
Bearish Trend 7 days ago
81%
MACD
ODDS (%)
Bullish Trend 7 days ago
80%
N/A
TrendWeek
ODDS (%)
Bearish Trend 7 days ago
80%
Bullish Trend 7 days ago
74%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
81%
Bearish Trend 7 days ago
81%
Advances
ODDS (%)
Bullish Trend 8 days ago
81%
Bullish Trend 12 days ago
73%
Declines
ODDS (%)
Bearish Trend 19 days ago
81%
Bearish Trend 15 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
84%
Bullish Trend 7 days ago
69%
Aroon
ODDS (%)
Bearish Trend 7 days ago
82%
N/A
View a ticker or compare two or three
Ad is loading...
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CMVRX13.590.13
+0.97%
Columbia Select Mid Cap Value R
FIFRX133.870.01
+0.01%
Franklin Growth R6
THCGX31.53N/A
N/A
Thornburg Small/Mid Cap Growth A
UGTCX27.29N/A
N/A
Victory Growth and Tax Strategy C
BOGSX7.25-0.03
-0.41%
Black Oak Emerging Technology

PCVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PCVX has been loosely correlated with ORKA. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if PCVX jumps, then ORKA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCVX
1D Price
Change %
PCVX100%
+0.11%
ORKA - PCVX
61%
Loosely correlated
-10.78%
LOGC - PCVX
45%
Loosely correlated
-1.78%
RXRX - PCVX
42%
Loosely correlated
-2.03%
DYN - PCVX
41%
Loosely correlated
-3.65%
MDXG - PCVX
36%
Loosely correlated
-1.04%
More

XNCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XNCR has been loosely correlated with RLAY. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if XNCR jumps, then RLAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XNCR
1D Price
Change %
XNCR100%
-1.67%
RLAY - XNCR
53%
Loosely correlated
+7.42%
VCYT - XNCR
52%
Loosely correlated
+2.99%
ERAS - XNCR
49%
Loosely correlated
-9.09%
AXON - XNCR
44%
Loosely correlated
-0.23%
INZY - XNCR
43%
Loosely correlated
-13.78%
More